Articles and Blog Entries for Prescription-Eyeglasses.com

The FDA has granted 510(k) clearance to Norlases Lion, a green laser photocoagulator integrated into an indirect ophthalmoscope, according to a press release. The device, now available in the United States, does not require a fiber optic connection. It is powered by a rechargeable battery and has an advanced wireless interface, with optional voice control of parameters. Lion is the culmination of advanced laser technology and thoughtful design based around optimizing the user experience and impr...

>Read More

Imaging with adaptive optics showed thickened retinal arteriole walls in patients with early diabetes compared with controls, according to a study presented here at the American Academy of Optometry virtual meeting. Adaptive optics ... enables us to correct for the eyes optical imperfections and allows high resolution imaging of living individual cells in the retina like photoreceptors and individual blood cells, study author Kaitlyn Sapoznik, OD, said at an academy-sponsored press conference. I...

>Read More

Shifts in daylight saving time have been shown to increase the risk for adverse health effects such as cardiovascular issues and injuries, according to research published in PLoS Computational Biology. For a recent study, Hanxin Zhang, a PhD candidate at the University of Chicago, and colleagues examined insurance claims from the United States and Sweden from 1968 to 2014. They estimated that each spring daylight saving time (DST) shift is associated with at least 880,000 negative health events ...

>Read More

An eye drop candidate designed to treat presbyopia has started phase 3 clinical studies, according to a press release from Orasis Pharmaceuticals. The multicenter, double-masked, parallel-group NEAR-1 and NEAR-2 trials are enrolling about 600 patients with presbyopia in the U.S. to investigate the efficacy and safety of the drop. Our proprietary eye drop formulation was designed to achieve the optimal balance between efficacy, safety and comfort. Promising results from our well-powered phase 2b ...

>Read More

The need for Octane to develop into a content providing forum, and the pursuit of continuing evolution and innovation were part of the introductory presentation at the organizations 2020 MedTech Innovation Forum. To say that this year has been different is an understatement, Bill Carpou, CEO of Octane, said during the opening presentation. It has tested the resolve of every individual and organization. Octane has been no different. Octanes monthly programming series, Ignite, which has allowed th...

>Read More

Oxymetazoline hydrochloride 0.1%, a preservative-free eye drop, was well tolerated and produced positive outcomes in the treatment of acquired ptosis, according to a study. Blepharoptosis (or ptosis) is an abnormal drooping of the upper eyelid margin with the eye in primary gaze, Charles B. Slonim, MD, of the department of ophthalmology, University of South Florida Morsani College of Medicine, and colleagues wrote. Standard of care is surgery, often targeting the upper eyelid retractor muscles. ...

>Read More

Overminus therapy, a method that has been used to control intermittent exotropia, was found to increase myopia progression, particularly in children who are already myopic, according to research presented at the American Academy of Optometry virtual meeting. While retrospective studies have suggested that overminus spectacles cause no more myopia progression than the natural rate of myopic change with age, Theres been concern that increased accommodative effort might increase myopia progression,...

>Read More

Prescription-Eyeglasses.com News and Blog